CVE-2024-0758
Published: 19 January 2024
Summary
CVE-2024-0758 is a medium-severity Cross-site Scripting (CWE-79) vulnerability in Ipb-Halle Molecularfaces. Its CVSS base score is 6.1 (Medium).
Operationally, exploitation aligns with the MITRE ATT&CK technique Exploit Public-Facing Application (T1190); ranked in the top 11.8% of CVEs by exploit likelihood; it is not currently listed in the CISA KEV catalog; a public proof-of-concept is referenced.
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2024-0445
Vulnerability details
MolecularFaces before 0.3.0 is vulnerable to cross site scripting. A remote attacker can execute arbitrary JavaScript in the context of a victim browser via crafted molfiles.
- CWE(s)
Related Threats
MITRE ATT&CK Enterprise TechniquesAI
Why these techniques?
The XSS vulnerability (CWE-79) in MolecularFaces enables remote attackers to execute arbitrary JavaScript in victims' browsers via crafted molfiles processed by the public-facing web application.
Affected Assets
Mitigating Controls
Likely Mitigating Controls AI
Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.
Penetration testing submits XSS payloads to web applications, detecting cross-site scripting flaws for subsequent remediation.
Validates web inputs to reject script-related content that could produce XSS.
Output validation against expected content can reject or sanitize script content in generated web pages, reducing XSS exploitability.